Abbvie

Market Cap (Mar-08-2026)

406.873 Billion USD

World Rank (Jan-05-2024)

32

Market Cap (Jan-05-2024)

285.064 Billion USD

World Rank (Jul-30-2023)

33

Market Cap (Jul-30-2023)

266.140 Billion USD

World Rank (Jan-07-2022)

46

Market Cap (Jan-07-2022)

238.450 Billion USD

World Rank (Jan-01-2021)

51

Market Cap (Jan-01-2021)

189.100 Billion USD

Company Rank in Country in 2023

Rank in USA in July-2023 is 24

Headquarters Country

USA

Nasdaq / NYSE Code

ABBV

CEO

Richard A. Gonzalez

Employee Count

50,000

Employee Count as of Date

As on Jan-2023

Headquarters City/State

Illinois

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

61,160 Million USD

Annual Operating Income in USD

15,075 Million USD

Annual Net Income in USD

4,226 Million USD

Annual Results for Period Ending

Dec-2025 ending year

Total Assets in USD

133,960 Million USD

Total Liabilities in USD

137,188 Million USD

Total Equity in USD

-3,228 Million USD

Balance Sheet for Period Ending

Dec-2025 ending year

Business Sector

Company Website

Abbvie - Healthcare and Bio-Pharmaceutical Company

Wikipedia

Yahoo

Yahoo @ NYSE

Facebook

Company Profile

Abbvie is USA based healthcare and pharmaceutical multi-national company. AbbVie is highly focus research-driven bio-pharmaceutical company. Headquarters is in USA.

Facts About Company

As on 2023, Abbvie has 50,000 employees.

Abbvie annual revenue generated for period ending Dec-2022 was 58,054 million USD.

Abbvie annual net income generated for period ending Dec-2022 was 11,782 million USD.

Abbvie annual revenue generated for period ending Dec-2021 was 56,197 million USD.

Abbvie annual net income generated for period ending Dec-2021 was 11,542 million USD.

Total Assets as on Dec-2022 was 138,805 Million USD.

As on 2020, Abbvie has 47,000 employees who are scientists, researchers, communicators, manufacturing specialists and regulatory experts located around the globe.

Annual Results Summary

Abbvie Inc - Yearly Revenue and Net Profit - in Million USD:

Fiscal Year	Fiscal Year End	Total Annual Revenue (USD mm)	*Gross Profit (USD mm)**	Operating Profit (USD mm)	Net Income (USD mm)**
2025	2025-12-31	61,160	42,956	15,075	4,226
2024	2024-12-31	56,334	39,430	9,137	4,278
2023	2023-12-31	54,318	33,903	12,757	4,863
2022	2022-12-31	58,054	40,640	18,117	11,836
2021	2021-12-31	56,197	38,751	17,924	11,542
2020	2020-12-31	45,804	30,417	11,363	4,616
2019	2019-12-31	33,266	25,827	12,983	7,882
2018	2018-12-31	32,753	25,035	6,383	5,687
2017	2017-12-31	28,216	21,174	9,545	5,309
2016	2016-12-31	25,638	19,806	9,340	5,953

Balance Sheet Summary

Abbvie Inc - Balance Sheet Summary - in Million USD:

Fiscal Year	Total Assets (USD million)	Total Liabilities (USD million)	Total Equity (USD million)
2025	133,960	137,188	(3,228)
2024	135,161	131,797	3,364
2023	134,711	124,314	10,397
2022	138,805	121,518	17,287
2021	146,529	131,093	15,436
2020	150,565	137,489	13,076
2019	89,115	97,287	(8,172)
2018	59,352	67,798	(8,446)
2017	70,786	65,689	5,097
2016	66,099	61,463	4,636

Founded Year

2013

Institutional Investors

Top 30 Institutional Investors in ABBVIE as on SEP-30-2023

RANK	INSTITUTION NAME	DATE	SHARES HELD	CHANGE (SHARES)	CHANGE (%)	VALUE (IN 1,000S)
1	VANGUARD GROUP INC	09/30/2023	16,07,47,355	14,50,089	0.91%	$22,192,780
2	BLACKROCK INC.	09/30/2023	13,80,16,856	-11,44,940	-0.82%	$19,054,607
3	STATE STREET CORP	09/30/2023	7,79,62,930	-2,19,637	-0.28%	$10,763,562
4	JPMORGAN CHASE & CO	09/30/2023	5,52,30,808	-15,41,772	-2.72%	$7,625,165
5	CAPITAL INTERNATIONAL INVESTORS	09/30/2023	4,24,45,720	-7,07,021	-1.64%	$5,860,056
6	GEODE CAPITAL MANAGEMENT, LLC	09/30/2023	3,62,07,172	12,54,234	3.59%	$4,998,762
7	CAPITAL RESEARCH GLOBAL INVESTORS	09/30/2023	3,19,76,144	-5,69,378	-1.75%	$4,414,626
8	MORGAN STANLEY	06/30/2023	3,12,61,042	-1,66,952	-0.53%	$4,315,899
9	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	09/30/2023	2,27,49,560	-47,492	-0.21%	$3,140,804
10	NORTHERN TRUST CORP	09/30/2023	2,19,36,279	4,91,391	2.29%	$3,028,523
11	BANK OF NEW YORK MELLON CORP	09/30/2023	2,03,56,072	3,52,817	1.76%	$2,810,359
12	BANK OF AMERICA CORP /DE/	09/30/2023	1,91,95,565	9,39,385	5.15%	$2,650,140
13	NORGES BANK	12/31/2022	1,87,69,556	9,97,293	5.61%	$2,591,325
14	AMERIPRISE FINANCIAL INC	09/30/2023	1,40,66,082	1,99,833	1.44%	$1,941,963
15	PRICE T ROWE ASSOCIATES INC /MD/	09/30/2023	1,28,14,568	-3,50,146	-2.66%	$1,769,179
16	LEGAL & GENERAL GROUP PLC	09/30/2023	1,20,94,534	-5,33,050	-4.22%	$1,669,771
17	FMR LLC	09/30/2023	1,12,71,472	3,71,842	3.41%	$1,556,139
18	GOLDMAN SACHS GROUP INC	09/30/2023	1,07,34,074	14,13,745	15.17%	$1,481,946
19	UBS GROUP AG	09/30/2023	1,05,59,985	-5,51,084	-4.96%	$1,457,912
20	NUVEEN ASSET MANAGEMENT, LLC	09/30/2023	1,04,52,705	-4,95,010	-4.52%	$1,443,100
21	JANUS HENDERSON GROUP PLC	09/30/2023	95,41,495	-11,81,766	-11.02%	$1,317,299
22	UBS ASSET MANAGEMENT AMERICAS INC	09/30/2023	94,06,247	-5,77,122	-5.78%	$1,298,626
23	WELLS FARGO & COMPANY/MN	09/30/2023	93,55,140	-2,35,881	-2.46%	$1,291,571
24	ROYAL BANK OF CANADA	09/30/2023	92,49,618	92,234	1.01%	$1,277,002
25	AMUNDI	09/30/2023	82,17,339	-8,38,371	-9.26%	$1,134,486
26	DIMENSIONAL FUND ADVISORS LP	09/30/2023	78,00,946	68,013	0.88%	$1,076,999
27	FRANKLIN RESOURCES INC	09/30/2023	72,31,896	1,10,691	1.55%	$998,436
28	INVESCO LTD.	09/30/2023	63,32,048	-2,92,483	-4.42%	$874,203
29	STATE FARM MUTUAL AUTOMOBILE INSURANCE CO	09/30/2023	63,18,360	0	0%	$872,313
30	T. ROWE PRICE INVESTMENT MANAGEMENT, INC.	09/30/2023	62,51,205	2,53,644	4.23%	$863,041